Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 2
1(20.0%)
5Total
N/A(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04738084Not ApplicableCompleted

Meru Health Program Versus Waitlist Control for Adults With Depression

Role: lead

NCT04744545Not ApplicableCompleted

RCT of Adjunctive Curcumin and the Meru Health Program

Role: lead

NCT05615662Not ApplicableWithdrawn

Meru Health Program to Treat Depression in Primary Care

Role: lead

NCT05588622Not ApplicableCompleted

Meru Health Program for Cancer Patients With Depression and Anxiety

Role: lead

NCT03652948Phase 2Completed

Meru Health Ascend Mobile Intervention for Depression in Middle Aged and Older Adults

Role: collaborator

All 5 trials loaded